The upregulation of Mmut and the consequent accumulation of methylmalonic acid in high-risk TEAD3 + melanoma cells suggest that targeting these metabolic pathways could disrupt tumor progression mechanisms, particularly in aggressive subtypes such as acral melanoma. The gene discussed is TEAD3; the disease is acral lentiginous melanoma.